| Dr Kevin Michael Maguire, MD | |
|
3100 Tongass Ave, Ketchikan, AK 99901-5746 | |
| (907) 228-8300 | |
| (907) 228-8332 |
| Full Name | Dr Kevin Michael Maguire |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 33 Years |
| Location | 3100 Tongass Ave, Ketchikan, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144256132 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | D0060912 (Maryland) | Secondary |
| 207L00000X | Anesthesiology | MEDS3156 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Peacehealth Ketchikan Medical Center | Ketchikan, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Peacehealth | 9436067618 | 39 |
News Archive
The scientists who led the team that developed Glybera, the first gene therapy drug approved for use in the Western world, provide a fascinating first-person account of their pioneering work in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Grand Challenges Canada today commended the Government of Canada's sustained leadership on maternal, newborn and child health, reaffirmed by The Honourable Minister Paradis, Minister of International Development and Minister for La Francophonie.
By launching Sona, the Sonova Group is introducing a novel business concept combining a specialized product portfolio with easy fitting and simplified logistic processes, which are unique in the industry. The new brand broadens the portfolio of the established hearing solutions of Phonak and Unitron and is aimed at the market segment for mild-to-moderate hearing loss. It features mainly the integrated service concept providing audiologists with new opportunities to make their hearing solutions more accessible to consumers.
Researchers from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, modified an experimental malaria vaccine and showed that it completely protected four of eight monkeys that received it against challenge with the virulent Plasmodium falciparum malaria parasite.
› Verified 2 days ago
| Entity Name | Peacehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801965736 PECOS PAC ID: 9436067618 Enrollment ID: O20031106000460 |
News Archive
The scientists who led the team that developed Glybera, the first gene therapy drug approved for use in the Western world, provide a fascinating first-person account of their pioneering work in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Grand Challenges Canada today commended the Government of Canada's sustained leadership on maternal, newborn and child health, reaffirmed by The Honourable Minister Paradis, Minister of International Development and Minister for La Francophonie.
By launching Sona, the Sonova Group is introducing a novel business concept combining a specialized product portfolio with easy fitting and simplified logistic processes, which are unique in the industry. The new brand broadens the portfolio of the established hearing solutions of Phonak and Unitron and is aimed at the market segment for mild-to-moderate hearing loss. It features mainly the integrated service concept providing audiologists with new opportunities to make their hearing solutions more accessible to consumers.
Researchers from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, modified an experimental malaria vaccine and showed that it completely protected four of eight monkeys that received it against challenge with the virulent Plasmodium falciparum malaria parasite.
› Verified 2 days ago
| Entity Name | Peacehealth |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1396705539 PECOS PAC ID: 9436067618 Enrollment ID: O20080114000791 |
News Archive
The scientists who led the team that developed Glybera, the first gene therapy drug approved for use in the Western world, provide a fascinating first-person account of their pioneering work in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Grand Challenges Canada today commended the Government of Canada's sustained leadership on maternal, newborn and child health, reaffirmed by The Honourable Minister Paradis, Minister of International Development and Minister for La Francophonie.
By launching Sona, the Sonova Group is introducing a novel business concept combining a specialized product portfolio with easy fitting and simplified logistic processes, which are unique in the industry. The new brand broadens the portfolio of the established hearing solutions of Phonak and Unitron and is aimed at the market segment for mild-to-moderate hearing loss. It features mainly the integrated service concept providing audiologists with new opportunities to make their hearing solutions more accessible to consumers.
Researchers from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, modified an experimental malaria vaccine and showed that it completely protected four of eight monkeys that received it against challenge with the virulent Plasmodium falciparum malaria parasite.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kevin Michael Maguire, MD 1329 Lusitana St Ste 604, Honolulu, HI 96813-2431 Ph: (808) 531-1116 | Dr Kevin Michael Maguire, MD 3100 Tongass Ave, Ketchikan, AK 99901-5746 Ph: (907) 228-8300 |
News Archive
The scientists who led the team that developed Glybera, the first gene therapy drug approved for use in the Western world, provide a fascinating first-person account of their pioneering work in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Grand Challenges Canada today commended the Government of Canada's sustained leadership on maternal, newborn and child health, reaffirmed by The Honourable Minister Paradis, Minister of International Development and Minister for La Francophonie.
By launching Sona, the Sonova Group is introducing a novel business concept combining a specialized product portfolio with easy fitting and simplified logistic processes, which are unique in the industry. The new brand broadens the portfolio of the established hearing solutions of Phonak and Unitron and is aimed at the market segment for mild-to-moderate hearing loss. It features mainly the integrated service concept providing audiologists with new opportunities to make their hearing solutions more accessible to consumers.
Researchers from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, modified an experimental malaria vaccine and showed that it completely protected four of eight monkeys that received it against challenge with the virulent Plasmodium falciparum malaria parasite.
› Verified 2 days ago
Geoffrey B Taylor, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3100 Tongass Ave, Ketchikan, AK 99901 Phone: 907-228-8300 Fax: 907-228-8332 |